WhitTier Trust Company’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.5M Sell
107,921
-336
-0.3% -$72.3K 0.51% 43
2026
Q1
$22.4M Buy
108,257
+4,211
+4% +$934K 0.46% 50
2025
Q4
$23.3M Sell
104,046
-329
-0.3% -$74.9K 0.48% 43
2025
Q3
$24.4M Buy
104,375
+1,870
+2% +$381K 0.52% 43
2025
Q2
$19M Buy
102,505
+973
+1% +$181K 0.43% 52
2025
Q1
$21.3M Buy
101,532
+813
+0.8% +$158K 0.54% 45
2024
Q4
$17.9M Buy
100,719
+1,297
+1% +$238K 0.44% 52
2024
Q3
$19.6M Sell
99,422
-841
-0.8% -$157K 0.51% 46
2024
Q2
$17.2M Buy
100,263
+99
+0.1% +$16.4K 0.48% 46
2024
Q1
$18.2M Buy
100,164
+32,593
+48% +$5.62M 0.52% 45
2023
Q4
$10.5M Sell
67,571
-1,725
-2% -$251K 0.34% 72
2023
Q3
$10.3M Sell
69,296
-1,780
-3% -$261K 0.37% 64
2023
Q2
$9.58M Sell
71,076
-525
-0.7% -$77K 0.32% 75
2023
Q1
$11.4M Buy
71,601
+741
+1% +$113K 0.42% 59
2022
Q4
$11.5M Sell
70,860
-80
-0.1% -$12.3K 0.45% 56
2022
Q3
$9.52M Buy
70,940
+1,013
+1% +$145K 0.41% 62
2022
Q2
$10.7M Sell
69,927
-1,214
-2% -$186K 0.44% 54
2022
Q1
$11.5M Buy
71,141
+4,529
+7% +$658K 0.42% 58
2021
Q4
$9.02M Buy
66,612
+514
+0.8% +$60.7K 0.33% 74
2021
Q3
$7.13M Buy
66,098
+197
+0.3% +$22.5K 0.29% 82
2021
Q2
$7.42M Sell
65,901
-266
-0.4% -$30K 0.31% 78
2021
Q1
$7.16M Buy
66,167
+3,242
+5% +$347K 0.32% 76
2020
Q4
$6.74M Sell
62,925
-449
-0.7% -$43.1K 0.34% 76
2020
Q3
$5.55M Sell
63,374
-413
-0.6% -$38.9K 0.32% 77
2020
Q2
$6.26M Buy
63,787
+1,623
+3% +$143K 0.39% 67
2020
Q1
$4.74M Sell
62,164
-743
-1% -$63.3K 0.36% 75
2019
Q4
$5.57M Sell
62,907
-18,892
-23% -$1.57M 0.36% 79
2019
Q3
$6.19M Sell
81,799
-12
-0% -$823 0.43% 61
2019
Q2
$5.95M Sell
81,811
-1,212
-1% -$95.3K 0.42% 66
2019
Q1
$6.69M Sell
83,023
-11,844
-12% -$969K 0.49% 54
2018
Q4
$8.75M Sell
94,867
-2,201
-2% -$194K 0.72% 37
2018
Q3
$9.18M Sell
97,068
-838
-0.9% -$79.5K 0.67% 42
2018
Q2
$9.07M Sell
97,906
-40
-0% -$3.91K 0.71% 35
2018
Q1
$9.27M Buy
97,946
+6,478
+7% +$712K 0.76% 35
2017
Q4
$8.85M Buy
91,468
+7,960
+10% +$750K 0.76% 34
2017
Q3
$7.42M Buy
83,508
+58
+0.1% +$4.42K 0.69% 40
2017
Q2
$6.05M Buy
83,450
+1,195
+1% +$80.3K 0.59% 52
2017
Q1
$5.36M Buy
82,255
+158
+0.2% +$9.93K 0.54% 55
2016
Q4
$5.14M Buy
82,097
+2,559
+3% +$156K 0.55% 54
2016
Q3
$5.02M Buy
79,538
+2,550
+3% +$165K 0.57% 52
2016
Q2
$4.77M Sell
76,988
-500
-0.6% -$30.5K 0.54% 58
2016
Q1
$4.42M Sell
77,488
-1,300
-2% -$72.5K 0.52% 60
2015
Q4
$4.67M Buy
78,788
+1,457
+2% +$83.9K 0.55% 57
2015
Q3
$4.21M Sell
77,331
-3,768
-5% -$245K 0.51% 60
2015
Q2
$5.45M Sell
81,099
-978
-1% -$63.8K 0.61% 54
2015
Q1
$4.8M Sell
82,077
-923
-1% -$55.8K 0.53% 62
2014
Q4
$5.43M Sell
83,000
-5,723
-6% -$361K 0.61% 57
2014
Q3
$5.12M Sell
88,723
-47
-0.1% -$2.61K 0.59% 54
2014
Q2
$5.01M Sell
88,770
-17,196
-16% -$902K 0.56% 57
2014
Q1
$5.45M Sell
105,966
-24,963
-19% -$1.26M 0.64% 53
2013
Q4
$6.92M Sell
130,929
-2,457
-2% -$121K 0.83% 30
2013
Q3
$5.96M Buy
133,386
+2,777
+2% +$123K 0.8% 31
2013
Q2
$5.4M Buy
+130,609
New +$5.71M 0.78% 35

Other funds holding ABBV

WhitTier Trust Company's ABBV Position: Q2 2026 in Review

WhitTier Trust Company reduced its AbbVie (ABBV) stake by 0.31% in Q2 2026, selling an estimated $72.3K and leaving 107,921 shares worth $27.5M. The position accounts for 0.51% of the portfolio, ranked #43.

WhitTier Trust Company first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 1,993 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • WhitTier Trust Company held 107,921 shares of AbbVie worth $27.5M as of Q2 2026.
  • WhitTier Trust Company sold 336 AbbVie shares in Q2 2026, an estimated $72.3K.
  • AbbVie made up 0.51% of WhitTier Trust Company's portfolio in Q2 2026, its #43 holding.
  • WhitTier Trust Company first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 1,993 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on WhitTier Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.